Canadian TTO Valuations of the EQ-5D-5L: East versus West Differences

Slides:



Advertisements
Similar presentations
Comparing different treatments How can we decide?.
Advertisements

Measuring outcomes Emma Frew October Measuring outcomes Learning objectives By the end of the session students should be able to – Explain how different.
1 Could there be a single European EQ tariff? Jan J.V. Busschbach, Ph.D. Former address: –iMTA, Erasmus university Present address: –Medical Psychology.
Big Q and Little Q revisited Christopher McCabe PhD Capital Health Endowed Research Chair in Emergency Medicine Research.
Using a discrete choice experiment with duration to estimate values for health states on the QALY scale Nick Bansback Assistant Professor School of Population.
1 Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
Health Economics II –2010 Health Economic Evaluations Part III Lecture 2 Cost-effectiveness analysis QALYs and cost-utility analysis Nils-Olov Stålhammar.
1 Dyslexia and Cost Effectiveness Prof. dr. Jan van Busschbach De Viersprong Erasmus MC.
1 EuroQol EQ-5D Jan J. V. Busschbach, Ph.D Psychotherapeutic Centrum ‘De Viersprong’, Halsteren Department of Medical.
Measuring and valuing health outcome Montarat Thavorncharoensap, Ph.D. 1: Faculty of Pharmacy, Mahidol University 2. HITAP, Thailand.
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
1 Health Economics  Comparing different allocations  Should we spent our money on Wheel chairs Screening for cancer  Comparing costs  Comparing outcome.
Overview of the EQ-5D Purpose and origins of the descriptive system.
STATISTICSSTATISTIQUECANADA Aboriginal Labour Force Survey Province of Alberta.
1 The valuation of disease-specific questionnaires for QALY analysis  To rescue data in absence of an utility measure  Growth hormone deficiency in adults.
Is healthcare any good for patients? Measuring health outcomes using EQ-5D Professor Paul Kind Principal Investigator Outcomes Research Group Centre for.
Economic evaluation of health programmes Department of Epidemiology, Biostatistics and Occupational Health Class no. 11: Cost-utility analysis – Part 4.
Chiu et al., CMAJ 2010 Do ethnic groups living in Ontario differ in their cardiovascular risk profiles? Maria Chiu, MSc, PhD Candidate Inst. of Medical.
Why use the EQ-5D? What are the alternatives?. What are the alternatives for Direct valuation? Other VAS Time Trade-Off Standard Gamble Willingness to.
New and ongoing areas of research In the EuroQol Group.
EQ-5D AND QUALITY OF LIFE OF OSTEOPOROSIS AT-RISK PATIENTS IN A SWEDISH OSTEOPOROSIS PATIENT REGISTRY Arun Krishna 1, Dan Mellström 2, Zhiyi Li 3, Chun-Po.
1 Patient values or values from the general public.
Poverty measurement: experience of the Republic of Moldova UNECE, Measuring poverty, 4 May 2015.
Sex Differences in Profiles and Outcomes of Patients with Traumatic Brain Injury in a National Rehabilitation Sample Dr. Angela Colantonio PhD, OT Reg.
Interactive Introduction cost effectiveness Jan J. v. Busschbach, Ph.D Viersprong Institute for studies on Personality Disorders (VISPD)
1 EQ-5D, HUI and SF-36 Of the shelf instruments…..
The third international stroke trial (IST-3) effect of thrombolysis on outcomes at 18 months in 2348 patients in long-term follow- up cohort The IST3 collaborative.
Overview of Health-Related Quality of Life Measures May 22, 2014 (1:00 – 2:00 PDT) Kaiser Methods Webinar Series 1 Ron D.Hays, Ph.D.
1 Health outcome valuation study in Thailand Sirinart Tongsiri Research degree student Health Services Research Unit, Public Health & Policy Department.
Using a Discrete Choice Experiment to Value the EQ-5D-5L in Canada Nick Bansback Assistant Professor School of Population and Public Health, University.
1 Interactive Introduction Cost Effectiveness and Psychotherapy Jan J. v. Busschbach, Ph.D. Psychotherapeutic Centrum ‘De Viersprong’, Halsteren
Applying Expectancy-value Model to understand Health Preference An Exploratory Study Xu-Hao Zhang Department of Pharmacy National University of Singapore.
Measuring Family HRQOL Spillover Effects Using QALYs Lisa A. Prosser, PhD University of Michigan CANS Special Topics Conference October 14, 2015.
Hermann P. G. Schneider, Alastair H. MacLennan and David Feeny
1 Families First Edmonton Family Characteristics, Family Functioning & Parental Wellbeing: Preliminary Analyses.
Measuring Disability: Results from the 2001 Census and the 2001 Post-Censal Disability Survey Statistics Canada January 10, 2003.
Health Related Quality of Life: Prevalence and Its Associate on the Intention to Leave Nursing Career. Nittaya Phosrikham.
“Introduction to Patient Preference Methods used for QALYs” Presented by: Jan Busschbach, PhD, Chair Section Medical Psychology and Psychotherapy, Department.
Cost-Effectiveness of Psychotherapy (for Personality Disorders) Prof. dr. Jan van Busschbach.
(Cost-)Effectiveness of Psychotherapy for Personality Disorders Jan van Busschbach Prof. Dr. J. van Busschbach Department of Medical Psychology and Psychotherapy.
Effect of framing of death on health state values obtained from DCEs Dr. Esther W. de Bekker-Grob by Jonker, de.
1 Cost-Effectiveness in Medicine An Interactive Introduction  Jan J. v. Busschbach, Ph.D.  Erasmus MC Institute for Medical Psychology and Psychotherapy.
Feng Xie Department of Clinical Epidemiology and Biostatistics McMaster University.
School of Population and Public Health PROMs to support informed patient decision making Nick Bansback, PhD Assistant Professor School of Population and.
LSE Summit Rethinking regulation and value assessment of medical technologies: challenges and opportunities Valentina Prevolnik Rupel, PhD Institute for.
Literacy, Knowledge, Health Beliefs, and Self-efficacy among Urban, Low-income, Obese African American Women Feleta L. Wilson, PhD, RN 1 May T. Dobal,
General Introduction Some Notes. Definition of Measurement “Measurement consists of rules for assigning numbers to observable attributes so as to represent.
From Victim to Survivor: Using Best Practices to Guide the Way Jessica Li, Executive Director, Asian/Pacific Islander Domestic Violence Resource Project.
1 Utilization of Quality of Life Research in Decision-Making and Policy  Prof. Dr. Jan J.V. Busschbach  Erasmus MC, Rotterdam, The Netherlands  Section.
Professor Nancy J. Devlin Office of Health Economics Royal Statistical Society June 18 th 2015 Measuring and ‘valuing’ patient reported health.
Darrell H. S. Tan1, Jayoti Rana1, Shawn Fowler2, Trevor A
Addressing the Health SDGs The Challenge of Disaggregation
Variation in health state preferences across local and international populations: East doesn’t meet West CADTH symposium Panel Session April 12, 2016.
M. Dakoutrou, V. Gerovasili, G. Sidiras, I. Patsaki, A. Kouvarakos, S
Patient Baseline Assessment
Lisa Weiss, M.D. Brian F. Pendleton, Ph.D. Susan Labuda Schrop, M.S.
Prof. Dr. Jan J.V. Busschbach
How useful is a reminder system in collection of follow-up quality of life data in clinical trials? Dr Shona Fielding.
Veterans with life-limiting illness: Baseline descriptors
Moving forward with ethnoburb and income inequality: A Preliminary Analysis Rafael Harun PhD Candidate in Planning University of Waterloo, ON,
Effect of framing of death on health state values obtained from DCEs
The valuation of disease-specific questionnaires for QALY analysis
Is healthcare any good for patients
Did not have a usual source of care Went without care because of cost
Impact of Mode and Order of Administration on Generic HRQOL Scores
Measuring outcomes Emma Frew October 2012.
Census topics selection
Canadian Women’s Foundation Awareness Report
How to Measure Quality of Life
Hazard risks for incident dementia by diverse social relationship engagement score. The scores are calculated by adding the number of selected social relationship.
Presentation transcript:

Canadian TTO Valuations of the EQ-5D-5L: East versus West Differences Jeffrey A. Johnson (on behalf of the Canadian EQ-5D-5L Valuation Study Team)

Acknowledgements Canadian EQ-5D-5L Valuation Study Team Principal Investigators: Feng Xie (McMaster University) and Jeffrey Johnson (U of Alberta) Co-Investigators: Nick Bansback, Stirling Bryan (UBC), Arto Ohinmaa (University of Alberta), Lise Poissant (University of Montreal), Eleanor Pullenayegum (McMaster/University of Toronto) Research Coordinator: Gaebel K (McMaster University) Research Assistants: Samantha Pollard & Lidia Engel (UBC); Serena Humphries & Fatima Al Sayah (U of Alberta), Touria Addou (University of Montreal). Funding support from CIHR and the EuroQol Research Foundation

EQ-5D Preference-based HRQL (“utility”) instrument 5-dimension classification system and VAS Can produce variety of health status/HRQL scores (5D profile, EQ-VAS, EQ-index) Preference-based scoring system provides index score suitable for QALYs Country-specific preference-based value sets recommended for local resource allocation decisions

EQ-5D Descriptive System EQ-5D-5L I have no problems in walking about I have slight problems in walking about I have moderate problems in walking about I have severe problems in walking about I am unable to walk about I have no problems washing or dressing myself I have slight problems washing or dressing myself I have moderate problems washing or dressing myself I have severe problems washing or dressing myself I am unable to wash or dress myself I have no problems doing my usual activities I have slight problems doing my usual activities I have moderate problems doing my usual activities I have severe problems doing my usual activities I am unable to do my usual activities I have no pain or discomfort I have slight pain or discomfort I have moderate pain or discomfort I have severe pain or discomfort I have extreme pain or discomfort I am not anxious or depressed I am slightly anxious or depressed I am moderately anxious or depressed I am severely anxious or depressed I am extremely anxious or depressed ☐ 3125 health states EQ-5D-3L Mobility I have no problems in walking about I have some problems in walking about I am confined to bed ☐ Self-Care I have no problems washing or dressing myself I have some problems washing or dressing myself I am unable to wash or dress myself ☐ Usual Activities I have no problems doing my usual activities I have some problems doing my usual activities I am unable to do my usual activities ☐ Pain/ Discomfort I have no pain or discomfort I have moderate pain or discomfort I have extreme pain or discomfort ☐ Anxiety Depression I am not anxious or depressed I am moderately anxious or depressed I am extremely anxious or depressed ☐ 243 health states

Canadian EQ-5D-5L Valuation Study Objective was to derive a value set for Canada for the new EQ-5D-5L, based on preferences from the general population in Canada. Med Care 2016; 54:98-105

EQ Valuation Technology (EQ-VT) Standardized, computer-based interview protocol Composite time trade-off (cTTO) 86 health states into 10 blocks (10 states/block) one of 5 very mild states (21111, 12111, 11211, 11121, 11112) is included in each block 55555 is included in each block Discrete choice experiment (DCE) 28 blocks (7 pairs per block) Demographics and feedback Recommended sample size: ~1000/country

cTTO-better than dead

CAN EQ-5D-5L Valuation Study Computer-assisted face-to- face interviews EQ-VT and supplemental component N= 300 in Vancouver Edmonton, Hamilton, and Montreal Various recruitment strategies: random digit-dialing, community posters Quota sampling in terms of age, sex, education

“Inconsistent” TTO Valuations Considered respondents with inconsistent valuations Based on Dominance: e.g. 21111 vs 31111 Number of health states dominated by the very mild state varied from 5 to 8 The exclusion criteria: a participant gave the same or lower score to the very mild health state than to 55555; and if a participant gave the same or lower score to the very mild health state than to the majority of the health states that are dominated by the very mild health state within the same block

Data Analysis Dependent variable TTO values (n=10/respondent) tTTO and positive cTTO values WTD values transformed for 0 to -1 scale TTOij = {MO + SC + UA + PD + AD} + age + sex + SES* + marital status + comorbidities + urban/rural + ethnicity + birth country + health literacy + EQ-VAS + {Vancouver/Edmonton/Hamilton/Montreal (ref)} +/- inconsistent valuations (Y/N) * education, employment, household income

TTO Valuations West versus East 0.02 -0.124 Adjusted regression results comparing cities to Montreal as reference – our a priori consideration that Montreal respondents may have been the most different (by language/culture) -0.156 * adjusted age, sex, SES*, marital status, comorbidities, urban/rural, ethnicity, birth country, health literacy, EQ-VAS & inconsistent valuations

TTO Valuations West versus East EQ-5D-5L Health State Vancouver (N=299) Edmonton (N=310) Hamilton (N=300) Montreal p-value 11112 (N=241) 0.72 0.88 0.93 0.90 0.001 12344 (N=109) 0.19 0.25 0.45 0.48 0.042 53243 (N=123) 0.10 0.17 0.53 55555 (N=1209) -0.13 -0.07 0.06 <0.001 To show some unadjusted differences in mean TTO valuations for 4 selected specific health states (mild, mild-mod, mod-severe, and worst). Note that the worst health stated ‘55555’ had mean values below 0 (worse than dead) for Vancouver and Edmonton, but positive average values for Hamilton and Montreal.

Sample Characteristics West versus East Vancouver (N=299) Edmonton (N=310) Hamilton (N=300) Montreal p-value Age (yr) 49.7 (18.8) 48.3 (17.5) 46.3 (16.8) 46.2 (16.0) <0.001 Sex (Female) 49% 44% 51% 37% Married/Common Law 42% 60% 58% 53% Household Income (<$75K) 75% Education (HS+) 89% 96% 88% Ethnicity White Aboriginal 50% 9% 63% 7% 71% 67% 5% Born in Canada 80% 83% 70% Urban Dwelling 81% 77% EQ-VAS 80.5 (14.7) 81.6 (13.9) 81.8 (14.9) 85.2 (12.9) Comorbidities (2+) 35% 36% 28% 24% Inconsistent Valuations 11% 6.5% 13% 14% To show that there were differences between samples within each city, but not in any particular pattern that would explain the West vs East differences we observed. Note that all of these factors were controlled for in the multivariate regression models – with and without inconsistent valuations included.

Discussion Socio-demographic characteristics (age, sex, urban dwelling) are important determinants of TTO valuations; Respondents from western Canadian cities provided substantially lower TTO valuations than form eastern cities Should one Canadian preference/value set be used for EQ-5D-5L ?

Discussion Same valuation methodology (EQ-VT) Differences in recruitment/samples by city…? Interviewer effect within study site…? N=1 for QC and ON; N=2 or 4 for BC or AB Differences in health care policy/delivery…? Differences in health preferences…? Again, should one Canadian EQ-5D-5L preference set be used for the whole country…??

If you have been…, thanks for listening.